Antheia CEO Joins Fierce JPM Week as Panelist Speaker on Onshoring Pharmaceutical Supply Chains

Barchart · 2d ago

MENLO PARK, Calif., Jan. 8, 2026 /PRNewswire/ -- Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced that CEO and co-founder, Dr. Christina Smolke will join Fierce JPM Week as a featured panelist. Dr. Smolke will discuss the historic effort to onshore pharmaceutical supply chains to the U.S. and the critical role of advanced biosynthesis and biomanufacturing in realizing this national priority.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.